COL5A1 | Collagen, type V, alpha 1 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
COL5A3 | Collagen, type V, alpha 3 | Cancer-related genes Predicted secreted proteins
| | | | | Mixed |
CREBBP | CREB binding protein | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CTCF | CCCTC-binding factor (zinc finger protein) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
CTNNB1 | Catenin (cadherin-associated protein), beta 1, 88kDa | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
CUL4B | Cullin 4B | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
CUX1 | Cut-like homeobox 1 | Cancer-related genes Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
DDX3X | DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
DDX5 | DEAD (Asp-Glu-Ala-Asp) box helicase 5 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
DIAPH1 | Diaphanous-related formin 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
DIS3 | DIS3 mitotic control homolog (S. cerevisiae) | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
DNAH12 | Dynein, axonemal, heavy chain 12 | Cancer-related genes
| | | | | Group enriched |
DNER | Delta/notch-like EGF repeat containing | Cancer-related genes Predicted membrane proteins
| | | | | Group enriched |
DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | Cancer-related genes Enzymes Plasma proteins Transcription factors
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EIF2S2 | Eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) | Cancer-related genes Transcription factors
| | | | | Mixed |
EP300 | E1A binding protein p300 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
EPHA2 | EPH receptor A2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ERBB3 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ERCC2 | Excision repair cross-complementing rodent repair deficiency, complementation group 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
EZH1 | Enhancer of zeste homolog 1 (Drosophila) | Cancer-related genes Enzymes
| | | | | Expressed in all |
EZH2 | Enhancer of zeste homolog 2 (Drosophila) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Mixed |
EZR | Ezrin | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
FAM166A | Family with sequence similarity 166, member A | Cancer-related genes
| | | | | Tissue enriched |
FAM46C | Family with sequence similarity 46, member C | Cancer-related genes
| | | | | Mixed |
FAT1 | FAT atypical cadherin 1 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
FBXW7 | F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase | Cancer-related genes Predicted secreted proteins
| | | | | Expressed in all |
FGFBP1 | Fibroblast growth factor binding protein 1 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enriched |
FGFR2 | Fibroblast growth factor receptor 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FLG | Filaggrin | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
FLT3 | Fms-related tyrosine kinase 3 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Mixed |
FOXA1 | Forkhead box A1 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
FOXQ1 | Forkhead box Q1 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
FRMD7 | FERM domain containing 7 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
GATA3 | GATA binding protein 3 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
GNA13 | Guanine nucleotide binding protein (G protein), alpha 13 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
GNB1 | Guanine nucleotide binding protein (G protein), beta polypeptide 1 | Cancer-related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
GNPTAB | N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
GUSB | Glucuronidase, beta | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
HIST1H1E | Histone cluster 1, H1e | Cancer-related genes
| | | | | Tissue enriched |
HIST1H3B | Histone cluster 1, H3b | Cancer-related genes
| | | | | Tissue enriched |
HIST1H4E | Histone cluster 1, H4e | Cancer-related genes Disease related genes
| | | | | Tissue enhanced |
HLA-B | Major histocompatibility complex, class I, B | Cancer-related genes Predicted membrane proteins
| | | | | Expressed in all |
HRAS | Harvey rat sarcoma viral oncogene homolog | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
HSP90AB1 | Heat shock protein 90kDa alpha (cytosolic), class B member 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
IDH1 | Isocitrate dehydrogenase 1 (NADP+), soluble | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
IDH2 | Isocitrate dehydrogenase 2 (NADP+), mitochondrial | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |